Cluster of linezolid-resistant Enterococcus faecium ST117 in Norwegian hospitals.

Kristin Hegstad, Jørn-Åge Longva, Reidar Hide, Bettina Aasnæs, Tracy M Lunde, Gunnar Skov Simonsen
{"title":"Cluster of linezolid-resistant Enterococcus faecium ST117 in Norwegian hospitals.","authors":"Kristin Hegstad,&nbsp;Jørn-Åge Longva,&nbsp;Reidar Hide,&nbsp;Bettina Aasnæs,&nbsp;Tracy M Lunde,&nbsp;Gunnar Skov Simonsen","doi":"10.3109/00365548.2014.923107","DOIUrl":null,"url":null,"abstract":"<p><p>A linezolid-resistant, vancomycin-susceptible Enterococcus faecium strain was isolated from 3 patients who had not received linezolid. The first patient was hospitalized in the same hospitals and wards as the 2 following patients. The E. faecium isolates were resistant to linezolid (minimum inhibitory concentration 8-32 mg/l), ampicillin, and high levels of gentamicin. Resistance to linezolid was associated with a G2576T mutation in 23S rDNA. The cfr linezolid resistance gene was not detected. The 3 isolates showed identical DNA fingerprints by pulsed-field gel electrophoresis, belonged to ST117, and harboured virulence genes esp, hyl, acm, efaAfm, srgA, ecbA, scm, pilA, pilB, and pstD typically associated with high-risk E. faecium genotypes. The linezolid-resistant E. faecium high-risk clone caused bacteraemia in the first 2 cancer patients and survived in the hospital environment for more than a year before appearing in the urethral catheter of the third patient.</p>","PeriodicalId":21541,"journal":{"name":"Scandinavian Journal of Infectious Diseases","volume":"46 10","pages":"712-5"},"PeriodicalIF":0.0000,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/00365548.2014.923107","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/00365548.2014.923107","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/8/19 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11

Abstract

A linezolid-resistant, vancomycin-susceptible Enterococcus faecium strain was isolated from 3 patients who had not received linezolid. The first patient was hospitalized in the same hospitals and wards as the 2 following patients. The E. faecium isolates were resistant to linezolid (minimum inhibitory concentration 8-32 mg/l), ampicillin, and high levels of gentamicin. Resistance to linezolid was associated with a G2576T mutation in 23S rDNA. The cfr linezolid resistance gene was not detected. The 3 isolates showed identical DNA fingerprints by pulsed-field gel electrophoresis, belonged to ST117, and harboured virulence genes esp, hyl, acm, efaAfm, srgA, ecbA, scm, pilA, pilB, and pstD typically associated with high-risk E. faecium genotypes. The linezolid-resistant E. faecium high-risk clone caused bacteraemia in the first 2 cancer patients and survived in the hospital environment for more than a year before appearing in the urethral catheter of the third patient.

挪威医院耐利奈唑胺屎肠球菌ST117聚集性病例
从3例未接受利奈唑胺治疗的患者中分离出一株耐利奈唑胺、万古霉素敏感的屎肠球菌。第一名患者与随后两名患者住在同一家医院和病房。菌株对利奈唑胺(最低抑菌浓度8 ~ 32mg /l)、氨苄西林和高浓度庆大霉素耐药。对利奈唑胺的耐药性与23S rDNA的G2576T突变有关。未检出cfr耐利奈唑胺基因。经脉冲场凝胶电泳鉴定,3株分离菌株DNA指纹图谱一致,均为ST117菌株,含有高危粪肠杆菌基因型相关的毒力基因esp、hyl、acm、efaAfm、srgA、ecbA、scm、pilA、pilB和pstD。耐利奈唑胺的粪肠杆菌高危克隆在前2例癌症患者中引起菌血症,并在医院环境中存活了一年多,才出现在第三例患者的尿道导管中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
4-8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信